top of page

Lebanese Dr. Jawad Youssef Fares, received the King Hussein Award for Cancer research 2022



Dr Jawad Fares receiving the award - Source Picture from Bint Jbeil Website

The Lebanese, son of the south, Dr. Jawad Youssef Fares, received the King Hussein Award for Cancer Research for the year 2022, which is the award for an emerging researcher in the international track.


Dr. Faris has multiple publications in high-impact journals such as PNAS, Translational Medicine for Science, and most recently in The Lancet Oncology.


His first paper, in The Lancet Oncology, describes the first use in humans of neural stem cells to deliver an implicated adenovirus in newly diagnosed patients with malignant glioma. Dr. Fares continues his research at Northwestern University's McGaw Medical Center.


The Hussein Prize for Cancer Research was launched in the year 2020, to enhance research efforts related to cancer in the Arab world, and in memory of the late King Hussein bin Talal of Jordan, who has always believed in the importance of cancer research; The award honors distinguished Arab researchers in the research field, whether they are researchers with long experience or promising ones.

The award aims to raise the level of Arab research and development, in order to understand the characteristics of cancer in the Arab region, and to study Arab genes in particular, so that we can confront the disease and overcome it by advanced scientific methods.


Prince Talal bin Muhammad, representing King Abdullah II of Jordan, honored the researchers who won the Hussein Prize for Cancer Research for the year 2022, at a ceremony organized by the King Hussein Cancer Foundation in the Jordanian capital, Amman, in the presence of the Chair of the Board of Trustees of the King Hussein Cancer Foundation and Center, Princess Ghida Talal and Princess Sumaya bint El Hassan.


Princess Ghida Talal said during the ceremony: "By celebrating this year the achievements of the Hussein Prize for Cancer Research winners, we pledge to advance cancer research in the Arab world for a future in which cancer will not have the last word, God willing." Prince Talal bin Muhammad handed shields to seven winners from Jordan, the United Arab Emirates, Lebanon, and the United States of America.


Out of 137 advanced researchers from 16 countries, all participants underwent an evaluation by a specialized jury for each category based on the principles of the award criteria, defined by the category of submission.




Comments


bottom of page